prescribing guide semaglutide tirzepatide Dose-equivalence reference based on pivotal GLP-1/dual-agonist trials: SURMOUNT-1 (tirzepatide/Zepbound, 72 weeks) STEP-1 (subcutaneous semaglutide/Wegovy, 68 weeks) OASIS-4 (oral semaglutide/Wegovy, 64 weeks). For educational comparison only—these are Prescribing pearls: Semaglutide and tirzepatide

The MHRA-approved indications specify appropriate patient selection criteria, and these medications should only be prescribed as part of a comprehensive weight management programme including dietary modification and increased physical activity

A consultation with a provider to determine candidacy is recommended

Target stubborn fat while preserving lean muscle with this dual-action blend

Regulatory status differences Epithalamin is approved in Russia for treatment of menopause-related symptoms, anovulatory infertility, and hormone-dependent tumors

Frequency: Severe deficiencies may require weekly injections initially, followed by maintenance doses every 1-3 months

It's my aim to make sure that you can have all the tools and resources in your hands and that we end the gatekeeping